As shoulder arthroplasty hits record highs, one specter continues to haunt even the most skilled surgeons: prosthetic joint infection (PJI). These aren’t your run-of-the-mill knee bugs—shoulder infections come with a unique set of microbial villains, diagnostic hurdles, and surgical challenges. But fear not. A new review published July 15, 2025, in The Journal of the American Academy of Orthopaedic Surgeons lays out a full-scale, evidence-backed war plan to keep PJIs out of your OR and off your postop rounds.
The article, titled “Shoulder Arthroplasty: Current Evidence and Techniques on Infection Prevention“ is authored by a squadron of heavy hitters: Garrett K. Berger, M.D., PharmD; Grant E. Garrigues, M.D.; Peter N. Chalmers, M.D.; and Anshuman Singh, M.D. Together, they present a layered, cross-phase infection prevention strategy that hits harder than cefazolin at induction.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
